{
  "title": "GSKâ€™s bid to dominate longer-life HIV drugs",
  "description": "Deborah Waterhouse and Dr Kimberly Smith have spent decades battling the deadly virus. In this edition of The Exchange podcast, the leaders of the British drug giant discuss breakthroughs in the $26 bln market and how Gilead is also making a play for the growing sector.\nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "pubDate": "Tue, 05 Jul 2022 09:33:12 -0000",
  "itunes:episodeType": "full",
  "itunes:author": "Reuters",
  "itunes:subtitle": "Deborah Waterhouse and Dr Kimberly Smith have spent decades battling the deadly virus. In this edition of The Exchange podcast, the leaders of the British drug giant discuss breakthroughs in the $26 bln market and how Gilead is also making a play for the growing sector.",
  "itunes:summary": "Deborah Waterhouse and Dr Kimberly Smith have spent decades battling the deadly virus. In this edition of The Exchange podcast, the leaders of the British drug giant discuss breakthroughs in the $26 bln market and how Gilead is also making a play for the growing sector.\nLearn more about your ad choices. Visit megaphone.fm/adchoices",
  "content:encoded": "<p>Deborah Waterhouse and Dr Kimberly Smith have spent decades battling the deadly virus. In this edition of The Exchange podcast, the leaders of the British drug giant discuss breakthroughs in the $26 bln market and how Gilead is also making a play for the growing sector.</p><p> </p><p>Learn more about your ad choices. Visit <a href=\"https://megaphone.fm/adchoices\">megaphone.fm/adchoices</a></p>",
  "itunes:duration": 1807,
  "guid": "c826abe0-fc44-11ec-8dff-ebc2278ba4d4",
  "enclosure": ""
}